NCT04662814 is a NA clinical trial of shock wave therapy in Primary Dysmenorrhea, sponsored by MTI University.

Who is sponsoring NCT04662814?

NCT04662814 is sponsored by MTI University.

What drugs are being tested in NCT04662814?

Interventions in NCT04662814: shock wave therapy, dietary modification.

What condition does NCT04662814 study?

NCT04662814 studies Primary Dysmenorrhea.

Is NCT04662814 still recruiting?

NCT04662814 is currently completed. Last updated 24 March 2021.

Last reviewed 2021-03-24 · How we verify

NCT04662814

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Extracorporeal Shock Wave Therapy for Dysmenorrhea

Completed NA Last updated 24 March 2021

What this trial tests

NA trial testing shock wave therapy in Primary Dysmenorrhea in 50 participants. Completed in 27 January 2021.

Timeline

12 September 2020

Primary endpoint
24 December 2020

27 January 2021

Quick facts

Lead sponsor	MTI University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	12 September 2020
Primary completion	24 December 2020
Estimated completion	27 January 2021
Sites	1 location across Egypt

Drugs / interventions tested

shock wave therapy
dietary modification

Conditions studied

Primary Dysmenorrhea — all drugs for Primary Dysmenorrhea →

Sponsor

MTI University

Who can join

Adults 18 to 25, female only, with Primary Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

purpose of this study to investigate the effect of Extracorporeal shock wave therapy on pain and prostaglandin level in patient with primary dysmenorrhea

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of shock wave therapy

Trials testing the same drug.

NCT06569615 — Efficacy of Extracorporeal Shock Wave Therapy, LASER Therapy and Cryotherapy in Patients Having Sacroiliitis · NA · recruiting
NCT06371885 — Shock Wave on Pillar Pain After Carpal Tunnel Release in Hand Burn · NA · active not recruiting
NCT05867888 — Shock Wave Therapy Versus Low Level Laser Therapy in Patients With Plantar Fasciitis · NA · completed
NCT05017636 — Effect of Shock Wave Therapy Without Biological and Immuno-histochemical Analysis. · NA · completed

Other recruiting trials for Primary Dysmenorrhea

Currently open trials in the same condition.

NCT07409337 — Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms · NA · recruiting
NCT06995287 — Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysme · Phase 3 · recruiting
NCT07352982 — Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea · NA · recruiting
NCT07239232 — "Knee Joint Position Sense and Dynamic Balance in Females With Primary Dysmenorrhea · recruiting
NCT07314021 — Primary Dysmenorrhea and Mobilization. · NA · active not recruiting

Other MTI University trials

Trials by the same sponsor.

NCT07510399 — Effect of Extracorporeal Radial Shock Wave Ibuprofen Phonophoresis on Subacromial Space in Patients With Impingement Syn · NA · not yet recruiting
NCT07394595 — Upper Versus Lower Limb Cycling Exercise With Electrical Muscle Stimulation on Perceptual Responses, Energy Feelings · NA · completed
NCT07196956 — Effect of Electromagnetic Field Therapy on Balance and Gait in Paraparetic Patients · NA · not yet recruiting
NCT07334847 — Anterior Foot Wedge With Neuromuscular Training for Balance in Parkinson's Disease · NA · not yet recruiting
NCT07365748 — Evaluation of Bacterial Contamination and Antimicrobial Efficacy on Charcoal-Infused vs, Standard Nylon Toothbrush Brist · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04662814 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by MTI University
Last refreshed: 24 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04662814.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing